New Chairman Appointed for GSTS Pathology
Monday 30, April 2012
The Board of GSTS Pathology LLP is pleased to announce the appointment of Christopher Baker as its new independent Chairman. This is a new role for the joint venture and Christopher’s appointment will be integral in helping GSTS Pathology develop its strategy for modernising NHS pathology and implement its plans to deliver sustainable growth of the business.
Christopher brings a wealth of relevant experience from both the public and private sectors. After an initial career in the Civil Service, he has held senior positions in corporate finance and corporate strategy and prior to embarking on a portfolio career was Corporate Strategy Director at Littlewoods plc. He is currently the chairman of Aintree University Hospital NHS Foundation Trust, a non-executive director of Park Group plc and Ai Claims Solutions plc and a lay member of the Council of Liverpool University. He was chair of the Training and Development Agency for Schools until the closure of the agency in March, 2012, and was awarded an MBE for services to education and the private sector in 2008
Richard Jones, CEO, GSTS Pathology said: “I am delighted to welcome Christopher as the new Chairman of GSTS pathology. This is a pivotal appointment to the Board and I believe that Christopher brings a superb mix of skills and experience to work with me and the Board to steer GSTS through the next phase of its development”.
Tim Smart, Chief Executive of King’s College Hospital commented: "The three owners of GSTS are delighted that Christopher Baker has joined us as non executive chair of the Board. There are many opportunities for us, and a Chair of Christopher's quality will ensure the highest standards of governance and probity. We look forward to working with him"
Christopher said: “GSTS has a hugely exciting opportunity to demonstrate how a public-private sector partnership can transform the delivery of a key healthcare service and support the NHS’s drive for efficiency. I am greatly looking forward to joining GSTS Pathology to support the delivery of this vision.”
Christopher takes up his post from 1st May 2012.